{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T22:33:29Z","timestamp":1785537209093,"version":"3.56.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,1,16]],"date-time":"2021-01-16T00:00:00Z","timestamp":1610755200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,16]],"date-time":"2021-01-16T00:00:00Z","timestamp":1610755200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurol Belg"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s13760-020-01574-1","type":"journal-article","created":{"date-parts":[[2021,1,16]],"date-time":"2021-01-16T10:02:36Z","timestamp":1610791356000},"page":"613-623","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Dopa-responsive dystonia, DRD-plus and DRD look-alike: a pragmatic review"],"prefix":"10.1007","volume":"121","author":[{"given":"Ajith","family":"Cherian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveen Kumar","family":"Paramasivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4695-8842","authenticated-orcid":false,"given":"K. P.","family":"Divya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,16]]},"reference":[{"issue":"10","key":"1574_CR1","first-page":"551","volume":"40","author":"D Beck","year":"1947","unstructured":"Beck D (1947) Dystonia musculorumdeformans with another case in the same family. Proc R Soc Med 40(10):551\u2013552","journal-title":"Proc R Soc Med"},{"issue":"7","key":"1574_CR2","first-page":"451","volume":"45","author":"BD Corner","year":"1952","unstructured":"Corner BD (1952) Dystonia musculorumdeformans in siblings; treated with artane (trihexyphenidyl). Proc R Soc Med 45(7):451\u2013452","journal-title":"Proc R Soc Med"},{"key":"1574_CR3","first-page":"667","volume":"24","author":"M Segawa","year":"1971","unstructured":"Segawa M (1971) Childhood basal ganglia disease with remarkable response to L-dopa, hereditary basal ganglia disease with marked diurnal fluctuation. Shinryo Tokyo 24:667\u2013672","journal-title":"Shinryo Tokyo"},{"key":"1574_CR4","first-page":"377","volume":"50","author":"TG Nygaard","year":"1988","unstructured":"Nygaard TG, Marsden CD, Duvoisin RC (1988) Dopa-responsive dystonia. AdvNeurol 50:377\u2013384","journal-title":"AdvNeurol"},{"issue":"1","key":"1574_CR5","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s13023-020-01379-8","volume":"15","author":"T Opladen","year":"2020","unstructured":"Opladen T, L\u00f3pez-Laso E, Cort\u00e8s-Saladelafont E et al (2020) Consensus guideline for the diagnosis and treatment of tetrahydrobiopterin (BH4) deficiencies. Orphanet J Rare Dis 15(1):126","journal-title":"Orphanet J Rare Dis"},{"issue":"6","key":"1574_CR6","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1002\/ana.410430614","volume":"43","author":"BS Jeon","year":"1998","unstructured":"Jeon BS, Jeong JM, Park SS, Kim JM, Chang YS, Song HC et al (1998) Dopamine transporter density measured by [123I]beta-CIT single-photon emission computed tomography is normal in dopa-responsive dystonia. Ann Neurol 43(6):792\u2013800","journal-title":"Ann Neurol"},{"issue":"28","key":"1574_CR7","doi-asserted-by":"publisher","first-page":"e184","DOI":"10.3346\/jkms.2018.33.e184","volume":"33","author":"W-W Lee","year":"2018","unstructured":"Lee W-W, Jeon B, Kim R (2018) Expanding the spectrum of Dopa-responsive dystonia (DRD) and proposal for new definition: DRD, DRD-plus, and DRD Look-alike. J Korean Med Sci 33(28):e184","journal-title":"J Korean Med Sci"},{"issue":"12","key":"1574_CR8","first-page":"1791","volume":"25","author":"C Pais\u00e1n-Ruiz","year":"2010","unstructured":"Pais\u00e1n-Ruiz C, Guevara R, Federoff M, Hanagasi H, Sina F, Elahi E et al (2010) Early-onset L-dopa-responsive parkinsonism with pyramidal signs due to ATP13A2, PLA2G6, FBXO7 and spatacsin mutations. MovDisord Off J MovDisordSoc 25(12):1791\u20131800","journal-title":"MovDisord Off J MovDisordSoc"},{"issue":"1\u20132","key":"1574_CR9","first-page":"25","volume":"213","author":"E Wilder-Smith","year":"2003","unstructured":"Wilder-Smith E, Tan EK, Law HY, Zhao Y, Ng I, Wong MC (2003) Spinocerebellar ataxia type 3 presenting as an L-DOPA responsive dystonia phenotype in a Chinese family. J NeurolSci 213(1\u20132):25\u201328","journal-title":"J NeurolSci"},{"issue":"3","key":"1574_CR10","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s00415-014-7250-x","volume":"261","author":"F Baschieri","year":"2014","unstructured":"Baschieri F, Batla A, Erro R, Ganos C, Cordivari C, Bhatia KP (2014) Paroxysmal exercise-induced dystonia due to GLUT1 mutation can be responsive to levodopa: a case report. J Neurol 261(3):615\u2013616","journal-title":"J Neurol"},{"issue":"6","key":"1574_CR11","first-page":"483","volume":"40","author":"M Hayashi","year":"2008","unstructured":"Hayashi M, Nagao Y, Kimura K, Hachimori K, Nomura Y, Segawa M (2008) Case of DYT1 dystonia (early-onset torsion dystonia) showing long-term focal dystonia in the arm. No Hattatsu Brain Dev 40(6):483\u2013486","journal-title":"No Hattatsu Brain Dev"},{"issue":"3","key":"1574_CR12","first-page":"425","volume":"24","author":"MS Luciano","year":"2009","unstructured":"Luciano MS, Ozelius L, Sims K, Raymond D, Liu L, Saunders-Pullman R (2009) Responsiveness to levodopa in epsilon-sarcoglycan deletions. MovDisordOff J MovDisordSoc 24(3):425\u2013428","journal-title":"MovDisordOff J MovDisordSoc"},{"issue":"13","key":"1574_CR13","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1212\/WNL.0b013e3182a55fa2","volume":"81","author":"G Charlesworth","year":"2013","unstructured":"Charlesworth G, Mohire MD, Schneider SA, Stamelou M, Wood NW, Bhatia KP (2013) Ataxia telangiectasia presenting as dopa-responsive cervical dystonia. Neurology 81(13):1148\u20131151","journal-title":"Neurology"},{"issue":"2","key":"1574_CR14","first-page":"149","volume":"2","author":"S Wijemanne","year":"2015","unstructured":"Wijemanne S, Shulman JM, Jimenez-Shahed J, Curry D, Jankovic J (2015) SPG11 mutations associated with a complex phenotype resembling dopa-responsive dystonia. MovDisordClinPract 2(2):149\u2013154","journal-title":"MovDisordClinPract"},{"issue":"1","key":"1574_CR15","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/S1474-4422(10)70269-6","volume":"10","author":"MA Kurian","year":"2011","unstructured":"Kurian MA, Li Y, Zhen J, Meyer E, Hai N, Christen H-J et al (2011) Clinical and molecular characterisation of hereditary dopamine transporter deficiency syndrome: an observational cohort and experimental study. Lancet Neurol 10(1):54\u201362","journal-title":"Lancet Neurol"},{"issue":"6","key":"1574_CR16","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1056\/NEJMoa1207281","volume":"368","author":"JJ Rilstone","year":"2013","unstructured":"Rilstone JJ, Alkhater RA, Minassian BA (2013) Brain dopamine-serotonin vesicular transport disease and its treatment. N Engl J Med 368(6):543\u2013550","journal-title":"N Engl J Med"},{"issue":"1","key":"1574_CR17","first-page":"115","volume":"52","author":"D Ebrahimi-Fakhari","year":"2015","unstructured":"Ebrahimi-Fakhari D, Maas B, Haneke C, Niehues T, Hinderhofer K, Assmann BE et al (2015) Disruption of SOX6 is associated with a rapid-onset dopa-responsive movement disorder, delayed development, and dysmorphic features. PediatrNeurol 52(1):115\u2013118","journal-title":"PediatrNeurol"},{"issue":"4","key":"1574_CR18","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.celrep.2014.07.016","volume":"8","author":"L Panman","year":"2014","unstructured":"Panman L, Papathanou M, Laguna A, Oosterveen T, Volakakis N, Acampora D et al (2014) Sox6 and Otx2 control the specification of substantia nigra and ventral tegmental area dopamine neurons. Cell Rep 8(4):1018\u20131025","journal-title":"Cell Rep"},{"issue":"7","key":"1574_CR19","first-page":"461","volume":"14","author":"W-W Lee","year":"2014","unstructured":"Lee W-W, Jeon BS (2014) Clinical spectrum of dopa-responsive dystonia and related disorders. CurrNeurolNeurosci Rep 14(7):461","journal-title":"CurrNeurolNeurosci Rep"},{"issue":"3","key":"1574_CR20","first-page":"408","volume":"12","author":"T Hanihara","year":"1997","unstructured":"Hanihara T, Inoue K, Kawanishi C, Sugiyama N, Miyakawa T, Onishi H et al (1997) 6-Pyruvoyl-tetrahydropterin synthase deficiency with generalized dystonia and diurnal fluctuation of symptoms: a clinical and molecular study. MovDisord 12(3):408\u2013411","journal-title":"MovDisord"},{"issue":"2","key":"1574_CR21","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1002\/med.10055","volume":"24","author":"A Ponzone","year":"2004","unstructured":"Ponzone A, Spada M, Ferraris S, Dianzani I, de Sanctis L (2004) Dihydropteridine reductase deficiency in man: from biology to treatment. Med Res Rev 24(2):127\u2013150","journal-title":"Med Res Rev"},{"issue":"3","key":"1574_CR22","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s10545-009-1067-2","volume":"32","author":"N Longo","year":"2009","unstructured":"Longo N (2009) Disorders of biopterin metabolism. J Inherit Metab Dis 32(3):333\u2013342","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"1574_CR23","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ymgme.2005.11.014","volume":"88","author":"JM Hevel","year":"2006","unstructured":"Hevel JM, Stewart JA, Gross KL, Ayling JE (2006) Can the DCoHalpha isozyme compensate in patients with 4a-hydroxy-tetrahydrobiopterin dehydratase\/DCoH deficiency? Mol Genet Metab 88(1):38\u201346","journal-title":"Mol Genet Metab"},{"issue":"1","key":"1574_CR24","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1055\/s-0038-1673630","volume":"50","author":"H Brennenstuhl","year":"2019","unstructured":"Brennenstuhl H, Jung-Klawitter S, Assmann B, Opladen T (2019) Inherited disorders of neurotransmitters: classification and practical approaches for diagnosis and treatment. Neuropediatrics 50(1):2\u201314","journal-title":"Neuropediatrics"},{"issue":"3","key":"1574_CR25","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/ng1194-236","volume":"8","author":"H Ichinose","year":"1994","unstructured":"Ichinose H, Ohye T, Takahashi E, Seki N, Hori T, Segawa M et al (1994) Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene. Nat Genet 8(3):236\u2013242","journal-title":"Nat Genet"},{"issue":"4","key":"1574_CR26","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1002\/1531-8249(200010)48:4<609::AID-ANA7>3.0.CO;2-H","volume":"48","author":"WL Hwu","year":"2000","unstructured":"Hwu WL, Chiou YW, Lai SY, Lee YM (2000) Dopa-responsive dystonia is induced by a dominant-negative mechanism. Ann Neurol 48(4):609\u2013613","journal-title":"Ann Neurol"},{"issue":"2","key":"1574_CR27","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1055\/s-0033-1337337","volume":"44","author":"M Segawa","year":"2013","unstructured":"Segawa M, Nomura Y, Hayashi M (2013) Dopa-responsive dystonia is caused by particular impairment of nigrostriatal dopamine neurons different from those Involved in Parkinson disease: evidence observed in studies on segawa disease. Neuropediatrics 44(2):61\u201366","journal-title":"Neuropediatrics"},{"issue":"12","key":"1574_CR28","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1001\/archneurol.2012.574","volume":"69","author":"V Tadic","year":"2012","unstructured":"Tadic V, Kasten M, Br\u00fcggemann N, Stiller S, Hagenah J, Klein C (2012) Dopa-responsive dystonia revisited: diagnostic delay, residual signs, and nonmotor signs. Arch Neurol 69(12):1558\u20131562","journal-title":"Arch Neurol"},{"issue":"8","key":"1574_CR29","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1136\/jnnp.2008.155861","volume":"80","author":"I Trender-Gerhard","year":"2009","unstructured":"Trender-Gerhard I, Sweeney MG, Schwingenschuh P, Mir P, Edwards MJ, Gerhard A et al (2009) Autosomal-dominant GTPCH1-deficient DRD: clinical characteristics and long-term outcome of 34 patients. J NeurolNeurosurg Psychiatry 80(8):839\u2013845","journal-title":"J NeurolNeurosurg Psychiatry"},{"issue":"6","key":"1574_CR30","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1212\/WNL.57.6.1121","volume":"57","author":"CK Kong","year":"2001","unstructured":"Kong CK, Ko CH, Tong SF, Lam CW (2001) Atypical presentation of dopa-responsive dystonia: generalized hypotonia and proximal weakness. Neurology 57(6):1121\u20131124","journal-title":"Neurology"},{"issue":"Pt 9","key":"1574_CR31","doi-asserted-by":"publisher","first-page":"2480","DOI":"10.1093\/brain\/awu179","volume":"137","author":"NE Mencacci","year":"2014","unstructured":"Mencacci NE, Isaias IU, Reich MM, Ganos C, Plagnol V, Polke JM et al (2014) Parkinson\u2019s disease in GTP cyclohydrolase 1 mutation carriers. Brain 137(Pt 9):2480\u20132492","journal-title":"Brain"},{"issue":"1","key":"1574_CR32","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/0888-7543(95)80101-Q","volume":"26","author":"B Th\u00f6ny","year":"1995","unstructured":"Th\u00f6ny B, Heizmann CW, Mattei MG (1995) Human GTP-cyclohydrolase I gene and sepiapterin reductase gene map to region 14q21-q22 and 2p14-p12, respectively, by in situ hybridization. Genomics 26(1):168\u2013170","journal-title":"Genomics"},{"issue":"1\u20132","key":"1574_CR33","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.ymgme.2006.03.010","volume":"89","author":"NG Abeling","year":"2006","unstructured":"Abeling NG, Duran M, Bakker HD, Stroomer L, Th\u00f6ny B, Blau N et al (2006) Sepiapterin reductase deficiency an autosomal recessive DOPA-responsive dystonia. Mol Genet Metab 89(1\u20132):116\u2013120","journal-title":"Mol Genet Metab"},{"issue":"5","key":"1574_CR34","first-page":"308","volume":"35","author":"B Echenne","year":"2006","unstructured":"Echenne B, Roubertie A, Assmann B, Lutz T, Penzien JM, Th\u00f6ny B et al (2006) Sepiapterin reductase deficiency: clinical presentation and evaluation of long-term therapy. PediatrNeurol 35(5):308\u2013313","journal-title":"PediatrNeurol"},{"issue":"4","key":"1574_CR35","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1002\/ana.22685","volume":"71","author":"J Friedman","year":"2012","unstructured":"Friedman J, Roze E, Abdenur JE, Chang R, Gasperini S, Saletti V et al (2012) Sepiapterin reductase deficiency: a treatable mimic of cerebral palsy. Ann Neurol 71(4):520\u2013530","journal-title":"Ann Neurol"},{"issue":"3","key":"1574_CR36","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/j.1399-0004.2009.01306.x","volume":"77","author":"V Leuzzi","year":"2010","unstructured":"Leuzzi V, Carducci CA, Carducci CL, Pozzessere S, Burlina A, Cerone R et al (2010) Phenotypic variability, neurological outcome and genetics background of 6-pyruvoyl-tetrahydropterin synthase deficiency. Clin Genet 77(3):249\u2013257","journal-title":"Clin Genet"},{"issue":"5","key":"1574_CR37","first-page":"435","volume":"3","author":"R Kim","year":"2016","unstructured":"Kim R, Jeon B, Lee W-W (2016) A systematic review of treatment outcome in patients with dopa-responsive dystonia (DRD) and DRD-plus. MovDisordClinPract 3(5):435\u2013442","journal-title":"MovDisordClinPract"},{"issue":"3","key":"1574_CR38","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1001\/archneur.65.3.387","volume":"65","author":"K-M Liu","year":"2008","unstructured":"Liu K-M, Liu T-T, Lee N-C, Cheng L-Y, Hsiao K-J, Niu D-M (2008) Long-term follow-up of Taiwanese Chinese patients treated early for 6-pyruvoyl-tetrahydropterin synthase deficiency. Arch Neurol 65(3):387\u2013392","journal-title":"Arch Neurol"},{"issue":"Pt 6","key":"1574_CR39","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1093\/brain\/awq087","volume":"133","author":"MA Willemsen","year":"2010","unstructured":"Willemsen MA, Verbeek MM, Kamsteeg E-J, de Rijk-van Andel JF, Aeby A, Blau N et al (2010) Tyrosine hydroxylase deficiency: a treatable disorder of brain catecholamine biosynthesis. Brain J Neurol 133(Pt 6):1810\u20131822","journal-title":"Brain J Neurol"},{"issue":"8","key":"1574_CR40","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1212\/01.WNL.0000142083.47927.0A","volume":"63","author":"A Schiller","year":"2004","unstructured":"Schiller A, Wevers RA, Steenbergen GCH, Blau N, Jung HH (2004) Long-term course of L-dopa-responsive dystonia caused by tyrosine hydroxylase deficiency. Neurology 63(8):1524\u20131526","journal-title":"Neurology"},{"issue":"2","key":"1574_CR41","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1177\/0883073810377014","volume":"26","author":"W-L Yeung","year":"2011","unstructured":"Yeung W-L, Wong VCN, Chan K-Y, Hui J, Fung C-W, Yau E et al (2011) Expanding phenotype and clinical analysis of tyrosine hydroxylase deficiency. J Child Neurol 26(2):179\u2013187","journal-title":"J Child Neurol"},{"issue":"6","key":"1574_CR42","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.braindev.2005.10.012","volume":"28","author":"WL Yeung","year":"2006","unstructured":"Yeung WL, Lam CW, Hui J, Tong SF, Wu SP (2006) Galactorrhea-a strong clinical clue towards the diagnosis of neurotransmitter disease. Brain Dev 28(6):389\u2013391","journal-title":"Brain Dev"},{"issue":"1","key":"1574_CR43","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1212\/WNL.0b013e3181e620ae","volume":"75","author":"L Brun","year":"2010","unstructured":"Brun L, Ngu LH, Keng WT, Chng GS, Choy YS, Hwu WL et al (2010) Clinical and biochemical features of aromatic L-amino acid decarboxylase deficiency. Neurology 75(1):64\u201371","journal-title":"Neurology"},{"key":"1574_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/8904_2017_54","volume":"40","author":"W-L Hwu","year":"2017","unstructured":"Hwu W-L, Chien Y-H, Lee N-C, Li M-H (2017) Natural history of aromatic l-amino acid decarboxylase deficiency in Taiwan. JIMD Rep 40:1\u20136","journal-title":"JIMD Rep"},{"key":"1574_CR45","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/8904_2014_327","volume":"17","author":"G Helman","year":"2014","unstructured":"Helman G, Pappa MB, Pearl PL (2014) Widening phenotypic spectrum of AADC deficiency, a disorder of dopamine and serotonin synthesis. JIMD Rep 17:23\u201327","journal-title":"JIMD Rep"},{"issue":"4","key":"1574_CR46","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1093\/brain\/awu022","volume":"137","author":"J Ng","year":"2014","unstructured":"Ng J, Zhen J, Meyer E, Erreger K, Li Y, Kakar N et al (2014) Dopamine transporter deficiency syndrome: phenotypic spectrum from infancy to adulthood. Brain 137(4):1107\u20131119","journal-title":"Brain"},{"issue":"3","key":"1574_CR47","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.ymgme.2013.01.001","volume":"108","author":"T Opladen","year":"2013","unstructured":"Opladen T, Hoffmann GF, K\u00fchn AA, Blau N (2013) Pitfalls in phenylalanine loading test in the diagnosis of dopa-responsive dystonia. Mol Genet Metab 108(3):195\u2013197","journal-title":"Mol Genet Metab"},{"issue":"8","key":"1574_CR48","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1007\/s00415-002-0776-3","volume":"249","author":"C-C Huang","year":"2002","unstructured":"Huang C-C, Yen T-C, Weng Y-H, Lu C-S (2002) Normal dopamine transporter binding in dopa responsive dystonia. J Neurol 249(8):1016\u20131020","journal-title":"J Neurol"},{"issue":"5","key":"1574_CR49","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1002\/ana.410340518","volume":"34","author":"BJ Snow","year":"1993","unstructured":"Snow BJ, Nygaard TG, Takahashi H, Calne DB (1993) Positron emission tomographic studies of dopa-responsive dystonia and early-onset idiopathic parkinsonism. Ann Neurol 34(5):733\u2013738","journal-title":"Ann Neurol"},{"issue":"3","key":"1574_CR50","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1002\/ana.410350317","volume":"35","author":"H Takahashi","year":"1994","unstructured":"Takahashi H, Levine RA, Galloway MP, Snow BJ, Calne DB, Nygaard TG (1994) Biochemical and fluorodopa positron emission tomographic findings in an asymptomatic carrier of the gene for dopa-responsive dystonia. Ann Neurol 35(3):354\u2013356","journal-title":"Ann Neurol"},{"issue":"1","key":"1574_CR51","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1006\/mgme.2001.3213","volume":"74","author":"N Blau","year":"2001","unstructured":"Blau N, Bonaf\u00e9 L, Th\u00f6ny B (2001) Tetrahydrobiopterin deficiencies without hyperphenylalaninemia: diagnosis and genetics of DOPA-responsive dystonia and sepiapterin reductase deficiency. Mol Genet Metab 74(1):172\u2013185","journal-title":"Mol Genet Metab"},{"issue":"4","key":"1574_CR52","first-page":"277","volume":"53","author":"LH Rodan","year":"2015","unstructured":"Rodan LH, Gibson KM, Pearl PL (2015) Clinical use of CSF neurotransmitters. PediatrNeurol 53(4):277\u2013286","journal-title":"PediatrNeurol"},{"issue":"5","key":"1574_CR53","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1212\/WNL.48.5.1290","volume":"48","author":"K Hyland","year":"1997","unstructured":"Hyland K, Fryburg JS, Wilson WG, Bebin EM, Arnold LA, Gunasekera RS et al (1997) Oral phenylalanine loading in dopa-responsive dystonia: a possible diagnostic test. Neurology 48(5):1290\u20131297","journal-title":"Neurology"},{"issue":"1","key":"1574_CR54","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/BF00711323","volume":"16","author":"JM Saraiva","year":"1993","unstructured":"Saraiva JM, Seakins JW, Smith I (1993) Plasma phenylalanine and tyrosine levels revisited in heterozygotes for hyperphenylalaninaemia. J Inherit Metab Dis 16(1):105\u2013109","journal-title":"J Inherit Metab Dis"},{"issue":"3","key":"1574_CR55","first-page":"477","volume":"47","author":"L Bonaf\u00e9","year":"2001","unstructured":"Bonaf\u00e9 L, Th\u00f6ny B, Leimbacher W, Kierat L, Blau N (2001) Diagnosis of dopa-responsive dystonia and other tetrahydrobiopterin disorders by the study of biopterin metabolism in fibroblasts. ClinChem 47(3):477\u2013485","journal-title":"ClinChem"},{"issue":"10","key":"1574_CR56","first-page":"1256","volume":"19","author":"Y Furukawa","year":"2004","unstructured":"Furukawa Y, Filiano JJ, Kish SJ (2004) Amantadine for levodopa-induced choreic dyskinesia in compound heterozygotes for GCH1 mutations. MovDisord 19(10):1256\u20131258","journal-title":"MovDisord"},{"issue":"Pt 7","key":"1574_CR57","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1093\/brain\/awp084","volume":"132","author":"F Clot","year":"2009","unstructured":"Clot F, Grabli D, Cazeneuve C, Roze E, Castelnau P, Chabrol B et al (2009) Exhaustive analysis of BH4 and dopamine biosynthesis genes in patients with dopa-responsive dystonia. Brain J Neurol 132(Pt 7):1753\u20131763","journal-title":"Brain J Neurol"},{"issue":"3","key":"1574_CR58","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1093\/hmg\/5.3.403","volume":"5","author":"O Bandmann","year":"1996","unstructured":"Bandmann O, Nygaard TG, Surtees R, Marsden CD, Wood NW, Harding AE (1996) Dopa-responsive dystonia in British patients: new mutations of the GTP-cyclohydrolase I gene and evidence for genetic heterogeneity. Hum Mol Genet 5(3):403\u2013406","journal-title":"Hum Mol Genet"},{"issue":"1","key":"1574_CR59","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1212\/WNL.40.1.66","volume":"40","author":"TG Nygaard","year":"1990","unstructured":"Nygaard TG, Trugman JM, de Yebenes JG, Fahn S (1990) Dopa-responsive dystonia: the spectrum of clinical manifestations in a large North American family. Neurology 40(1):66\u201369","journal-title":"Neurology"},{"issue":"4","key":"1574_CR60","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1002\/ana.410350405","volume":"35","author":"AH Rajput","year":"1994","unstructured":"Rajput AH, Gibb WRG, Zhong XH, Shannak KS, Kish S, Chang LG et al (1994) Dopa-responsive dystonia: pathological and biochemical observations in a case. Ann Neurol 35(4):396\u2013402","journal-title":"Ann Neurol"},{"issue":"1","key":"1574_CR61","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s13023-017-0685-2","volume":"12","author":"AMJ van Wegberg","year":"2017","unstructured":"van Wegberg AMJ, MacDonald A, Ahring K, B\u00e9langer-Quintana A, Blau N, Bosch AM et al (2017) The complete European guidelines on phenylketonuria: diagnosis and treatment. Orphanet J Rare Dis 12(1):162","journal-title":"Orphanet J Rare Dis"},{"issue":"S6","key":"1574_CR62","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.1002\/ana.10630","volume":"54","author":"M Segawa","year":"2003","unstructured":"Segawa M, Nomura Y, Nishiyama N (2003) Autosomal dominant guanosine triphosphate cyclohydrolase I deficiency (Segawa disease). Ann Neurol 54(S6):S32-45","journal-title":"Ann Neurol"},{"issue":"8","key":"1574_CR63","first-page":"1058","volume":"28","author":"R Pons","year":"2013","unstructured":"Pons R, Syrengelas D, Youroukos S, Orfanou I, Dinopoulos A, Cormand B et al (2013) Levodopa-induced dyskinesias in tyrosine hydroxylase deficiency. MovDisord 28(8):1058\u20131063","journal-title":"MovDisord"}],"container-title":["Acta Neurologica Belgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-020-01574-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13760-020-01574-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-020-01574-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T02:46:20Z","timestamp":1666752380000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13760-020-01574-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,16]]},"references-count":63,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["1574"],"URL":"https:\/\/doi.org\/10.1007\/s13760-020-01574-1","relation":{},"ISSN":["0300-9009","2240-2993"],"issn-type":[{"value":"0300-9009","type":"print"},{"value":"2240-2993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,16]]},"assertion":[{"value":"28 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}